Lupin Pharmaceuticals Inc.: Ramipril Capsules USP 5 mg, a) 90 count (NDC 68180-590-09), b) 100 count NDC 68180-590-01), and c) 500 count (NDC 68180-590-02) bottles, Rx only, Manufactured for Lupin Pha

Hazard

CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor

Details from the source

Reason for recall: CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor Distribution: Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide. Quantity: 146,322 bottles Lot/code info: a) NDC 68180-590-09; Lots G326928, exp. date 30-Sep-25, GA00964, exp. date 31-Dec-25, b) NDC 68180-590-01, Lots G326897, G326929, exp. date 30-Sep-25, GA00854, GA00933, GA00954, exp. date 31-Dec-25, c) NDC 68180-590-02, Lot GA00955, exp. date 31-Dec-25

Source

Official record: FDA (Drug enforcement) ↗

Republished from the official source above; details can change — the source record controls.